NW Recovery Centers Logo
News

A Washington Judge Ordered Albertsons to Pay $900 Million for the Opioid Pills Its Pharmacies Filled

A King County judge ruled Albertsons pharmacies failed to clear red flags on 6.5 million opioid prescriptions, then ordered $900 million for abatement.

7 min readBy NW Recovery Centers Editorial Team
Editorial illustration of a courthouse steps silhouette, a pharmacy storefront outline and stacked documents in a warm ochre and navy palette

A King County Superior Court judge ruled on Thursday that Albertsons violated Washington law by failing to guard against the misuse and diversion of opioid painkillers at its pharmacies, and ordered the grocery chain to pay $900 million, plus fees and costs, to address the damage.

Judge Janet Helson issued the ruling after a bench trial that opened on July 13 and ran roughly two months. Albertsons owns and operates more than 200 pharmacies in Washington under its Albertsons, Safeway and Haggen banners.

This was not a settlement. It was a judgment from the bench, and it closed a case the state filed in 2022 under then-Attorney General Bob Ferguson. Albertsons was the last defendant standing: according to the Attorney General's Office, the other pharmacy chains named in the suit either settled early or later declared bankruptcy.

"Pharmacies are supposed to be the last line of defense," Kelsey Endres of the Attorney General's Office said in her opening statement in July.

What the judge found

The state's theory was narrow and mechanical. Federal and state law require pharmacists to identify "red flags of diversion" — warning signs that a controlled substance may be misused or diverted — then investigate them, resolve them, and document that they did.

Between 2006 and 2022, according to the Attorney General's Office, Albertsons dispensed more than 641 million opioid pills into Washington. In total, the office says, its pharmacies unlawfully filled red-flagged opioid prescriptions more than 6.5 million times without documenting any effort to confirm the prescriptions were written for legitimate medical purposes.

The state also alleged that Albertsons distributed opioids to its own stores for a period and failed to report tens of thousands of suspicious in-house orders to the Drug Enforcement Administration, as required — shipping them instead.

The trial record included inventory failures with hard numbers: the Attorney General's Office says one Safeway employee in North Bend stole more than 70,000 opioid pills over two years before being caught, with other thefts of 12,000 pills in Leavenworth and 19,000 in Olympia.

Staffing was part of the state's evidence too. According to the release, Albertsons pharmacists wrote to superiors that under current workloads it was "impossible" to review prescriptions for legitimacy before filling them, that they were vomiting "due to exhaustion, dehydration, and hunger," and that they felt "all stretched like rubber bands that are about to snap." One pharmacist warned the company that "mistakes can easily be made to put someone's life at risk."

The state also argued that Albertsons kept accepting discount cards for controlled substances after other chains stopped, because the cards let patients and prescribers avoid insurer scrutiny — and that internal documents described users arriving as "refugees" from chains that had barred the practice.

The company's defense

Albertsons denied wrongdoing and argued that the prescribing — not the filling — drove the crisis.

"The part that the state always leaves out is doctors hold the only key," attorney Enu Mainigi said at the trial's opening, according to the Washington State Standard. "Without a doctor's prescription, the gate does not open. So when doctors wrote more prescriptions, pharmacies like ours received more prescriptions to be filled."

Mainigi also told the court the state's list of red-flagged cases was inaccurate, and that while Albertsons could have done better in isolated cases, "a small number of mistakes did not cause or substantially contribute to the opioid epidemic." The company said its policies evolved as standards changed.

Where the money actually goes

The Attorney General's Office says the verdict "will expand treatment and prevention resources throughout Washington." What it will not do is hand a check to a family or a clinic.

Washington's opioid money has an architecture. Under the allocation agreements the office publishes, settlement funds are split 50% to cities and counties and 50% to the state, with a separate memorandum of understanding dividing the local share among municipalities, and the money restricted to opioid remediation — abating the crisis, not general budget relief.

That framework is written for settlements, and this is a judgment. The Attorney General's Office's release does not say how the $900 million will be apportioned between state and local governments, or on what timeline it can be collected while post-trial motions and any appeal run their course.

The office's own tally also moved fast. Its trial-opening release in July, and its settlement pages, put total recoveries at "more than $1.3 billion" for state and local governments. Thursday's release puts the figure at $2.17 billion. Prior pieces of that total include $47.5 million from Kroger in 2024, $105.6 million from the Purdue/Sackler settlement, $123.34 million from Johnson & Johnson, and more than 54,000 free naloxone kits delivered by Teva.

The part that complicates the headline

The verdict landed while Washington's overdose curve is bending downward, not upward.

CDC provisional counts for the 12 months ending in September 2025 — the high point in the current series — put Washington at 3,159 total overdose deaths, of which 2,536 involved opioids and 2,336 involved synthetic opioids other than methadone. For the 12 months ending in May 2026, the predicted totals are 2,528 overall, 1,901 opioid-involved and 1,711 synthetic-opioid-involved. That is roughly a quarter fewer opioid deaths year over year, with about 15% of the May deaths still pending investigation.

Both things are true at once. The state's July release said "opioid deaths are higher than ever" and counted more than 26,000 Washingtonians dead since 1999, with more than 7,400 in the prior three years — those statements were accurate when written, and the decline since then does not undo them. But it does change the question. Money arriving as deaths fall is money that has to be spent deliberately, on capacity that did not exist during the peak, rather than on catching up with a rising line.

What happens next

The judgment is not the end of the litigation. Post-trial motions and an appeal are the ordinary next steps for a defendant that denied liability throughout, and the Attorney General's Office release does not state whether Albertsons will appeal or when payment would begin.

Albertsons has been settling these cases elsewhere. In April 2026 it agreed to pay $774 million to resolve opioid lawsuits filed around the country, according to the Washington State Standard — a deal that did not cover Washington's case.

For the state and its cities and counties, the practical questions are the same ones that follow every opioid dollar: how quickly the money becomes available, which abatement uses it is spent on, and whether the counties with the highest overdose rates see any of it. Those decisions get made in budget offices and council chambers, not courtrooms, and they are usually public — which is the reason to watch them.

For families in Washington right now, treatment access does not wait for the appeal. The SAMHSA National Helpline (1-800-662-4357) is free, confidential and staffed 24/7 in English and Spanish; 988 handles mental health and suicide crises; and FindTreatment.gov lists sliding-scale and Medicaid-accepting programs by ZIP code. Medication for opioid use disorder — buprenorphine, methadone, naltrexone — remains the intervention with the strongest evidence behind it (here is how each one works), and it is available in Washington regardless of what a judge ordered a grocery chain to pay. If cost is the barrier, this guide covers the payment routes that exist before any settlement dollar reaches a clinic.

Sources